Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.69
+1.151.65%
Volume:319.31K
Turnover:22.37M
Market Cap:5.90B
PE:-115.89
High:70.84
Open:69.42
Low:69.05
Close:69.54
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.49
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.68
PE(LYR):9.09

Loading ...

PTC Therapeutics raises 2026 revenue view to $1.08B-$1.18B, consensus $990.78M

TIPRANKS
·
May 08

GUIDANCE: (PTCT) PTC Therapeutics Expects Full Year 2026 Total Revenue Range $1.08 Billion to $1.18 Billion

MT Newswires Live
·
May 08

Earnings Flash (PTCT) PTC Therapeutics Posts Q1 Loss $0.03 a Share, vs. FactSet Est of $0.47 Loss

MT Newswires Live
·
May 08

PTC Therapeutics Q1 product revenue rises 47%, raises FY guidance

Reuters
·
May 08

PTC Therapeutics Q1 EPS $(0.03) Beats $(0.48) Estimate, Sales $272.551M Beat $218.805M Estimate

Benzinga Earnings
·
May 08

BRIEF-PTC Therapeutics Q1 Net Income USD -2.809 Million

Reuters
·
May 08

PTC Therapeutics Q1 EPS USD -0.03

THOMSON REUTERS
·
May 08

PTC Therapeutics Inc - Raises 2026 Product Revenue Guidance to $750-$850 Mln

THOMSON REUTERS
·
May 08

PTC Therapeutics executives to speak at Bank of America health care conference

Reuters
·
May 04

Earning Preview: PTC Therapeutics this quarter’s revenue is expected to increase by 34.16%, and institutional views are bullish

Earnings Agent
·
Apr 30

Is PTC Therapeutics (PTCT) Pricing Reflect Recent Pipeline Progress And Volatile Share Performance

Simply Wall St.
·
Apr 29

Barclays Keeps Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Apr 29

PTC Therapeutics Reports Positive 24-Month Votoplam Data

TIPRANKS
·
Apr 29

PTC Therapeutics Inc - Votoplam Continues to Show Favorable Safety Profile

THOMSON REUTERS
·
Apr 29

PTC Therapeutics Reports Positive Topline Results From Month 24 Interim Analysis of Pivot-Hd Extension Study of Votoplam

THOMSON REUTERS
·
Apr 29

PTC Therapeutics Inc - Votoplam Shows 52% Slowing of Disease Progression at 10 Mg Dose in Stage 2 Hd

THOMSON REUTERS
·
Apr 29

PTC Therapeutics to report 24-month interim results from PIVOT-HD extension study

Reuters
·
Apr 28

PTC Therapeutics to Report Results From Pivot-Hd Long Term Extension Study

THOMSON REUTERS
·
Apr 28

PTC Therapeutics CEO Makes Notable Move With Latest Stock Sale

TIPRANKS
·
Apr 24

Tectonic Therapeutic appoints Jessica Chutter to board of directors

Reuters
·
Apr 24